This inventor holds 4 USPTO granted patents. Top assignees: Agency of Industrial Science and Technology, National Institute of Advanced Industrial Science and Technology. Active years: 1985-2006.
Company Filing History:
2 out of 1,430 
2 out of 1,763 
Years Active: 1985-2006
Title: Seiji Yasuda: Innovator in Leukemia Treatment
Introduction
Seiji Yasuda is a notable inventor based in Tosu, Japan. He has made significant contributions to the field of therapeutic treatments for leukemia, holding a total of 4 patents. His innovative approaches focus on the selective targeting of leukemic cells, showcasing his dedication to advancing medical science.
Latest Patents
Yasuda's latest patents include an efficient method for therapeutic treatment of leukemic patients. This method involves bringing the patient's body fluid into direct contact with an adsorbent material that specifically and selectively adsorbs leukemic cells. The adsorbent material is a conjugate of a lectin protein extracted from beans or soybeans, coupled with a physiologically inert carrier material. Another significant patent details a method for inhibiting the growth of human leukemic cells using a medicament containing methylsulfinylalkyl isothiocyanates. This compound, derived from certain plants, has shown remarkable therapeutic effects while being less harmful to normal cells.
Career Highlights
Throughout his career, Seiji Yasuda has worked with esteemed organizations such as the National Institute of Advanced Industrial Science and Technology and Japan as represented by the Secretary of the Agency of Industrial Science and Technology. His work in these institutions has allowed him to develop and refine his innovative treatment methods.
Collaborations
Yasuda has collaborated with notable colleagues, including Osamu Nakamura and Hideki Ohba. Their combined expertise has contributed to the advancement of research in leukemia treatment.
Conclusion
Seiji Yasuda's contributions to leukemia treatment through his innovative patents highlight his role as a significant figure in medical research. His work continues to inspire advancements in therapeutic methods for patients suffering from this challenging disease.